DuPont de Nemours (NYSE: DD), globally-renowned biotech firm, saw some shifting treasury positions among investment firms during recent times.
Point72, both in Italy and Hong Kong, trimmed and expanded their positions respectively. while other firms, such as
Ameriprise Financial,
Nuveen Asset Management, and
Cresset Asset Management also downsized DD holdings. However,
Deutsche Bank,
Gotham Asset Management, and
Centiva Capital increased their stake significantly.
DD also revealed its forthcoming electronics spin-off,
Qnity, initiating new investment interest. The company displayed a promising financial landscape by topping Q1 earnings and revenue estimates. Investors seem optimistic about DD as they eagerly await the upcoming earnings release. A point of concern is the potential impact of tariffs, affecting current economic position.
Several investment banks including
J.P. Morgan,
Morgan Stanley, and
Keybanc have revised their price targets for DD. However, amidst market volatility, DD shares recorded a 26% slide in the last quarter. Despite this, DD remains a popular dividend stock, and is among the top material stocks recommended by hedge funds.
Dupont De Nemours DD News Analytics from Wed, 09 Apr 2025 07:00:00 GMT to Sat, 17 May 2025 11:42:17 GMT -
Rating 3
- Innovation -3
- Information 8
- Rumor -4
